Danaher Other Income (Expense) increased by 16.1% to -$73.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.6%, from -$79.00M to -$73.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -16.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $97.00M | $137.00M | $76.00M | -$20.00M | -$87.00M | -$51.00M | -$69.00M | $24.00M | -$15.00M | -$47.00M | -$137.00M | -$36.00M | -$59.00M | $102.00M | -$63.00M | -$79.00M | -$42.00M | -$14.00M | -$87.00M | -$73.00M |
| QoQ Change | — | +41.2% | -44.5% | -126.3% | -335.0% | +41.4% | -35.3% | +134.8% | -162.5% | -213.3% | -191.5% | +73.7% | -63.9% | +272.9% | -161.8% | -25.4% | +46.8% | +66.7% | -521.4% | +16.1% |
| YoY Change | — | — | — | — | -189.7% | -137.2% | -190.8% | +220.0% | +82.8% | +7.8% | -98.6% | -250.0% | -293.3% | +317.0% | +54.0% | -119.4% | +28.8% | -113.7% | -38.1% | +7.6% |